Curcumin suppresses renal carcinoma tumorigenesis by regulating circ-FNDC3B/miR-138-5p/IGF2 axis

Li Xue1, Yuhua Tao2, Yanjuan Yuan3

  • 1Departments of Nephrology.

Anti-Cancer Drugs
|May 18, 2021
PubMed

Insights

Curcumin inhibits renal carcinoma by downregulating circ-FNDC3B and upregulating miR-138-5p, impacting the IGF2 pathway. This study reveals curcumin

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Renal carcinoma (kidney cancer) is a significant health concern.
  • The precise mechanisms by which curcumin affects renal carcinoma tumorigenesis are not fully understood.
  • Circular RNAs (circRNAs) and microRNAs (miRNAs) are increasingly recognized for their roles in cancer development.

Purpose of the Study:

  • To elucidate the mechanism of curcumin's action in renal carcinoma.
  • To investigate the roles of circ-FNDC3B, miR-138-5p, and IGF2 in renal carcinoma.
  • To explore the therapeutic potential of curcumin in renal carcinoma.

Main Methods:

  • Quantitative reverse transcription PCR and Western blot to measure molecular levels.
  • Cell proliferation and apoptosis assays (MTT, colony formation, flow cytometry).
  • Dual-luciferase reporter assays to confirm molecular interactions.
  • In vivo xenograft model to assess anti-tumor effects.

Main Results:

  • Elevated circ-FNDC3B and decreased miR-138-5p were observed in renal carcinoma tissues and cells.
  • Curcumin suppressed renal carcinoma cell proliferation and induced apoptosis.
  • Circ-FNDC3B and miR-138-5p modulated curcumin's effects; circ-FNDC3B knockdown promoted apoptosis via miR-138-5p.
  • IGF2 was identified as a target of miR-138-5p and positively regulated by circ-FNDC3B.
  • Curcumin reduced tumor growth in vivo by decreasing circ-FNDC3B.

Conclusions:

  • Curcumin suppresses renal carcinoma tumorigenesis through the circ-FNDC3B/miR-138-5p/IGF2 axis.
  • This pathway offers novel insights into renal carcinoma development and potential therapeutic strategies.
  • Circ-FNDC3B and miR-138-5p are key mediators of curcumin's anti-cancer effects in renal carcinoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K